HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jian-Qing Mi Selected Research

Biomarkers (Surrogate Marker)

1/2022Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia.
3/2011Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jian-Qing Mi Research Topics

Disease

6Neoplasms (Cancer)
06/2022 - 11/2006
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2022 - 06/2014
4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
06/2022 - 01/2018
3Hematologic Neoplasms (Hematological Malignancy)
12/2021 - 10/2013
3Acute Promyelocytic Leukemia
01/2021 - 06/2015
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2014 - 04/2013
3Leukemia
06/2014 - 02/2011
2Hemorrhage
05/2022 - 04/2018
2Multiple Myeloma
01/2019 - 01/2018
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2015 - 08/2010
1Residual Neoplasm
06/2022
1Essential Thrombocythemia
06/2022
1Hemophilia A (Haemophilia)
05/2022
1Thrombosis (Thrombus)
05/2022
1Atherosclerosis
05/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018
1Lymphoma (Lymphomas)
10/2013
1Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
03/2011
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2006

Drug/Important Bio-Agent (IBA)

5Arsenic Trioxide (Trisenox)FDA Link
01/2021 - 08/2010
3Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2021 - 06/2015
2Histones (Histone)IBA
06/2022 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2011
2Chimeric Antigen ReceptorsIBA
12/2021 - 01/2019
1N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA
06/2022
1Histone Deacetylase InhibitorsIBA
06/2022
1interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA
06/2022
1Hydroxyurea (Hydrea)FDA LinkGeneric
06/2022
1FibrinIBA
05/2022
1Factor VIII (Coagulation Factor VIII)IBA
05/2022
1Antineoplastic Agents (Antineoplastics)IBA
02/2022
1blinatumomabIBA
02/2022
1AntibodiesIBA
02/2022
1Lysine (L-Lysine)FDA Link
01/2021
1B-Cell Maturation AntigenIBA
01/2019
1artemisinin (artemisinine)IBA
01/2018
1Antimalarials (Antimalarial Agents)IBA
01/2018
1SM1044IBA
01/2018
1RNA (Ribonucleic Acid)IBA
01/2018
1Bortezomib (Velcade)FDA Link
11/2015
1Glucose (Dextrose)FDA LinkGeneric
09/2014
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
10/2013
1alpha-hydroxyglutarateIBA
10/2013
1FenretinideIBA
04/2013
1DNA (Deoxyribonucleic Acid)IBA
03/2011
1MethyltransferasesIBA
03/2011
1Cytarabine (Cytosar-U)FDA LinkGeneric
02/2011
1Dasatinib (BMS 354825)FDA Link
02/2011
1Histocompatibility Antigens Class IIBA
11/2006

Therapy/Procedure

6Therapeutics
12/2021 - 06/2014
3Immunotherapy
02/2022 - 11/2006
1Lasers (Laser)
05/2022
1Drug Therapy (Chemotherapy)
01/2021
1Induction Chemotherapy
01/2018
1Transplantation
06/2014